JACARDI as a proof-of-concept for Europe’s Safe Hearts Plan

A new commentary in the International Journal of Public Health explores how JACARDI supports the translation of Europe’s Safe Hearts Plan into practical implementation. Activities conducted across JACARDI’s portfolio of over 140 pilots are generating practical implementation evidence on how public health strategies can be translated into practical action to prevent cardiovascular disease and diabetes. The authors argue that coordinated, life course-based approaches, combining prevention, early detection and integrated care, are essential to reduce the burden of these conditions across Europe.

Cardiovascular disease remains the leading cause of premature mortality and disability in the European Union. The article, by lead author Benedetta Armocida and other contributors from the joint action, highlights that the main challenge is not the lack of strategies, but how to implement them effectively and equitably across different health systems.

The article presents JACARDI as a proof-of-concept for implementing the EU Safe Hearts Plan. A key message is that cardiovascular disease and diabetes should be addressed together using a life course approach, recognising that risk factors build up over time. Early actions, such as health literacy programmes for children and young people, can support long-term health outcomes.

Linking detection, care and everyday support

The authors highlight that screening is effective only when it is connected to follow-up care. JACARDI pilots test different approaches, including community-based screening, mobile units and digital tools linked to lifestyle support.

The commentary also emphasises integrated care and self-management. Pilot interventions like a co-designed mobile application to optimize secondary prevention in Madrid and care pathways co-developed with patients and caregivers in the Basque Country demonstrate that digital and telemedicine solutions can support continuity of care and help people manage their condition in everyday life.

Equity and data as key priorities

The article underlines the importance of strong data systems and a focus on equity. Shared data models enable better monitoring of health outcomes and differences between population groups. Inclusive, targeted approaches are needed to ensure that prevention and care reach everyone.

Overall, the commentary highlights that JACARDI provides a practical model for turning policy into action. The authors conclude that combining a life course approach, integrated care and equity-focused implementation can support long-term improvements in cardiovascular health across Europe.

Read more: Commentary on JACARDI and the Safe Hearts Plan

Publication: Closing the implementation gap: the Joint Action on Cardiovascular Diseases and Diabetes (JACARDI) as a proof-of-concept for Europe’s Safe Hearts Plan

Authors: Benedetta Armocida et al. (on behalf of the JACARDI Implementation Board)

Journal: International Journal of Public Health

Publication date: 15 June 2026

DOI: https://doi.org/10.3389/ijph.2026.1609906

From promising ideas to real impact: WHO’s Quick Buys for combating NCDs

What if targeted actions could transform public health across Europe in just five years? This was the question posed at an event organized by the WHO European Region, where experts gathered to unveil and discuss the groundbreaking paper ‘Quick buys for prevention and control of noncommunicable diseases’. The study, conducted by experts in noncommunicable diseases (NCDs) at WHO/Europe, has for the first time analysed exactly how 25 specific public health measures, so-called quick buys, can have a positive impact on population health across Europe and central Asia in as little as 5 years.

NCDs are the leading cause of death and disability worldwide. In Europe, they account for 90% of all deaths and 85% of disability, including mental ill health. A significant proportion of NCD deaths are premature, before the age of 70 and an estimated 60% of all avoidable NCD deaths are due to preventable causes. These could be addressed by reducing alcohol and tobacco use, unhealthy diets and physical inactivity.

However, progress on NCD prevention has stalled, as highlighted by the WHO Europe’s European Health Report 2024 and the UN’s 2025 NCD progress report. These publications show a rise in obesity and diabetes and insufficient progress toward meeting global NCD targets by 2030. With just 25 weeks remaining until the 4th UN High-Level Meeting on NCDs, the clock is ticking to accelerate progress toward reducing premature mortality from NCDs. In line with this objective, JACARDI supports countries in reducing the burden of cardiovascular diseases and diabetes at the individual and health system levels.

From best buys to quick buys: a roadmap for action

Dr Benedetta Armocida, coordinator of JACARDI, emphasized during the event the transformative potential of these interventions. “Advancing cost-effective policies is a global health priority. This paper makes a critical contribution by introducing structured timeframes, an essential component for strategic planning, implementation and impact assessment”.

WHO has previously identified a set of best buys, proven, cost-effective measures to address NCDs. Now, it can show which of those measures deliver the fastest results. The 25 quick buys, published in The Lancet Regional Health – Europe [1], include policies targeting key risk factors and disease groups.

The 25 quick buys with proven impact within 5 years

These measures are designed to yield high-impact results in record time, making them indispensable in the current public health landscape. Professor David Stuckler, from the University of Bocconi and co-author of the paper, echoed the urgency: “This paper is a roadmap for action. There are no more excuses not to implement it”.

The quick buys focus on practical measures. For example, pharmacological treatment of hypertension in adults, treatment of myocardial infarctions with acetylsalicylic acid, and treating strokes with intravenous thrombolytic therapy have all an impact of less than a year.

The role of Joint Actions: JACARDI and JA PreventNCD

As a Joint Action initiative, JACARDI exemplifies how research and policy can align to drive meaningful change.

1. Provide evidence on feasibility, scalability and sustainability

The study on quick buys underscores the need for more natural experiments to assess the real-world impact of interventions. “This is precisely where Joint Actions like JACARDI can play a crucial role. By generating robust implementation research, Joint Actions provide essential evidence on feasibility, scalability and sustainability of interventions. JACARDI serves as a bridge between research and policy, facilitating the translation of evidence into concrete, actionable strategies at national and regional level”, explained Dr Armocida.

2. Creating a platform for knowledge exchange

Stakeholder cooperation and a multi-sectoral approach is another aspect highlighted by the JACARDI coordinator. “By fostering cooperation among Member States and key EU stakeholders and diverse sectors, Joint Actions can create a platform for knowledge exchange, capacity building and coordinated policy responses. This collaborative approach extends beyond national boundaries, contributing to a more integrated and effective NCDs prevention and control framework at European level”, concluded Dr Armocida.

3. Ensuring the effectiveness and equity of monitoring systems

In line with this, Dr Hanna Tolonen, representing JACARDI’s sister project called JA PreventNCD, emphasized the vital importance of monitoring systems in ensuring the effectiveness and equity of public health interventions: “Within JA PreventNCD, we are working on the monitoring aspects to see how countries are currently tracking progress and how we can support them in improving their surveillance activities”.

By leveraging collaborative initiatives like these and integrating evidence-based strategies, the path forward becomes clearer and more achievable. The message from the WHO/Europe event is clear: the time for action is now. This is the way to turn promising ideas into tangible health outcomes for all.

Source:
[1] Gauden Galea, Allison Ekberg, Angela Ciobanu, Marilys Corbex, Jill Farrington, Carina Ferreira-Bores, Daša Kokole, María Lasierra Losada, Maria Neufeld, Ivo Rakovac, Elena Tsoy, Kremlin Wickramasinghe, Julianne Williams, Martin McKee, David Stuckler, Quick buys for prevention and control of noncommunicable diseases

The Lancet Regional Health – Europe, 2025, 101281, ISSN 2666-7762